• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Bot Image's ProstatID AI Software Gains FDA Nod

    Researchers Develop Deep Learning Model for Eye Disorder Screening

    Medidata Unveils New Tech to Improve Clinical Trial Oversight

    BD, Direct Relief, NACHC Award $1M Grant for Health Equity

    Domestic Production Key to India's Medtech Manufacturing Success
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Xact Wire EDM Corp.

    Trademark Plastics Inc.

    Concise Engineering

    JBC Technologies

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing

    3 Ways Privacy-Enhancing Technology Will Improve Medical Products Innovation
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Xact Wire EDM Corp.

    Trademark Plastics Inc.

    Concise Engineering

    JBC Technologies

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Features

    Time to Outsource Your Molding Needs?

    The advantages may make it worthwhile, but a company needs to understand the critical factors of the “make vs. buy” decision.

    Time to Outsource Your Molding Needs?
    In support of a customer’s decision to outsource its molding, MGS built a new 15,000-square-foot Class 8 cleanroom to successfully take over the program and de-risk the manufacturing process. All images courtesy of MGS.
    Time to Outsource Your Molding Needs?
    In support of one of its customer’s complex molding needs, MGS leveraged its expertise in complex, high-cavitation molds to build a 144-cavity tool.
    Time to Outsource Your Molding Needs?
    Custom molders can offer innovative solutions—like MGS’ four-sided rotary stack system that accommodates press sizes up to 3,000 tons—to streamline the manufacturing process.
    Time to Outsource Your Molding Needs?
    MGS’ Germantown location is home to multiple state-of-the-art ISO Class 8 cleanroom facilities that enable MGS to deliver excellence in the integration of tooling, molding, and equipment for customers.
    Related CONTENT
    • Innovation in Medtech: Choosing an Execution Strategy
    • Hologic Partners with MagView to Develop Unifi EQUIP Solution
    • Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls
    • CarThera Receives FDA Approval for Phase 1/2a Trial in Glioblastoma
    • Cytek Biosciences Achieves ISO 9001:2015 Certification
    Bob Bordignon, Vice President of Global Sales, MGS07.30.19
    Today’s medical device OEMs are faced with two major choices when it comes to molding custom plastic components: partner with a custom injection molder or build out the capacity in-house, working with the supply chain as needed to ensure the use of the right tools, design processes, and integration of secondary operations.

    Some OEMs choose to mold parts and products in-house to maintain control over processes, protect intellectual property, and integrate into the larger work stream. Many often struggle, however, to maintain the proper level of resource investment necessary given the capital-intense nature of the injection molding business.

    Frequently, the original decision to mold in-house to save costs, streamline the supply chain, and protect intellectual property causes OEMs to be left scrambling when things go wrong. Whether the program gets derailed by poor quality tooling, the wrong downstream equipment, or a lack of ongoing investment and resources, it’s important to ask, “Is it time to outsource our molding business?”

    Members of management at OEMs struggling with the answer to this question should try to break down the current situation:
    • Do you find yourself struggling to maintain an ongoing investment in the operations—especially in cutting-edge molding and tooling technologies that can enhance your product offering?
    • Is a lack of reinvestment in your molding operations standing in the way of consistent quality and delivery?
    • Are you missing opportunities to allow your employees to innovate and drive greater success because their time is spent managing or troubleshooting molding?
    • Are you doubting your ability to hit your profitability targets?
    For anyone who answered “yes” to any of these questions, it’s time to give outsourcing a serious look. From understanding the “why” behind keeping a business in-house to understanding how working with an outsource partner produces less risk and more reward, this article will explain why outsourcing injection molding needs may be the right next step.

    Managing the Ongoing Investment
    When making the initial decision of how to manufacture plastic molded parts, there are plenty of positives to bringing the work in-house. You alone have control over the investment, part quality, timeline, and potential integration into the larger manufacturing operation. For some OEMs, molding programs continue to be a significant part of their ongoing competencies and business performance. However, with growing complexity, pressure to get to market faster, and a need for positive financial performance, managing in-house injection molding operations may prove detrimental to the long-term success of the company’s programs.

    It can be easy for many companies to overlook how resource investments could be better spent helping gain a bigger market advantage. To understand this, companies must review the “make vs. buy” decision holistically to understand the best strategy for them.

    Complexity in Making the ‘Make’ Decision
    In understanding the “make vs. buy” decision, OEMs often decide to maintain control of their molding operations as they feel it represents a lower-cost, more efficient way to get plastic parts manufactured. There are three key questions, however, that managers at these businesses should ask themselves prior to making the decision:
    • Am I concerned that I won’t maintain control over my intellectual property?
    • Are we leveraging our team in the best way possible to set our employees and our company up for success?
    • Have I considered all of the costs that will be needed to maintain the high level of performance needed for this product?
    Unfortunately, there are many cases where OEMs are not accurately accounting for all of the costs—both hard and soft—associated with maintaining and continuously improving in-house molding operations.

    Maintaining Control Over Intellectual Property
    In the highly competitive medical product industry, intellectual property (IP) can be critical to maintaining a firm hold on market share. As such, initial decisions to bring molding operations in-house are often based on a strategy that further ensures protection of IP, which can be deeply embedded in the design or manufacturing process of the plastic parts. In those cases, further insurance of proper protection can be gained by molding in-house.

    OEMs, however, must be sure to understand ways in which IP can be protected throughout the outsourcing partnership. Understand the IP assets, the risks involved (e.g., loss of market share), and the best way to protect those assets (e.g., non-disclosure agreements, strong contracts, thoroughly vetting the outsource partner, etc.). Weighing these concerns with the overall benefit of outsourcing will help managers factor in the value of partnering with a custom molder.

    Investing in Human Resources
    A robust injection molding operation requires significant human resource investments and support. As top talent in the industry becomes harder to find and keep, OEMs struggle to attract candidates and justify the increasing costs of human capital. The conflict comes into play when deciding whether to hire plastics processing experts versus hiring product designers, R&D engineers, or chemists who more closely tie to the OEM’s core business.

    Further, in-house molding programs can also inhibit the existing team’s ability to drive new, innovative programs. As most brand owners continue to focus on new product introductions that leverage their brand and distribution channels, the conversion of pellets into parts becomes an added distraction and strain on the organization. The question then becomes, “Should I be a better molder, or a product innovator?” The asking and/or answering of that question often triggers the exploration into the outsourcing of OEM molding operations to better enable the team to fill that role.

    Uncovering the True Costs of Molding In-House
    Initial decisions to bring operations in-house are often based upon a strategy that seeks a low-cost, efficient way to get quality plastic parts manufactured. Once these lines are up and running and initial startup costs (e.g., new equipment, tooling, materials, and staff) have been invested, however, OEMs may discover they’re experiencing an unexpected drain on their internal resources.

    Throughout the lifecycle of the molding operations, additional costs arise that can include ongoing capital investment, maintenance costs for general upkeep, added resources needed when processes malfunction, additional time working with third parties to troubleshoot, and more. For OEMs with complex, critical parts, these areas must be the focus of continuous reinvestment to sustain high-quality performance.

    Throughout this process, financials are analyzed and senior leaders weigh in, placing increased pressure on making the right decision. For larger OEM organizations, costs can be allocated to many departments and are difficult to accurately assign to the total cost of molding plastics parts. For example, tooling engineering to support a molding site may be absorbed as a corporate charge instead of being accounted for as a cost to mold. This can create discrepancies when assessing whether or not to outsource molding, and leaves the decision maker with an incomplete picture of current costs versus savings. Once total actual costs are captured, a savings in outsourcing is normally identified.

    Understanding the Capital Investment
    Once the commitment needed to “make” from a general cost and strategy perspective is understood, it’s important to recognize the specifics of the expenditures required, since the capital investment necessary to set up and maintain a competitive molding operation is significant. From ensuring the current facilities are well-equipped to managing the new production line to understanding if additional investment in machinery or facilities is needed, the capital investment related to in-house molding should not be considered lightly.

    The processing and handling of plastic parts typically requires a large footprint, decreasing an OEM’s ability to expand successful, innovative product lines and add new ones. This increasingly impacts companies in the face of rapid growth and consolidation in the industry, which is causing medical device and product manufacturers to consolidate product lines, businesses, and processes at an unprecedented pace. In outsourcing molded parts, an OEM is freeing up capacity of both the team and the facility to better manage product lines within a capital-intensive space. Additionally, in-house molding also consumes considerable energy. Regions with high energy costs and venerable supply add an additional element of risk to the cost model.

    Breaking Down the Investment
    As an example, MGS worked with a leading pharmaceutical company which did the cost modeling to retool an outdated and non-compliant facility that annually manufactured 2 billion small components for a drug delivery device. The initial cost to rebuild was estimated to be $30 million for the OEM. What the analysis didn’t take into consideration, however, was future annual investment, which could have reached seven figures. Of course, this cost also increases as the original investment ages.

    This reality initiated a “make vs. buy” evaluation, while illustrating that outsourcing would be a beneficial option. What would be a significant internal investment for a medical device OEM, in comparison, is simply considered “table stakes” to a custom molder who partners with medtech firms.

    Designing a Better Way
    Within the highly regulated landscape of medical product manufacturing, the molding environment, quality systems, and risk mitigation necessary in the manufacturing processes can also be a concern. Not too long ago, these concepts were foreign to the custom plastic molding industry. This fact forced healthcare OEMs to set up and run their plastic parts in-house as an extension of their manufacturing capabilities.

    The acceptance and expansion of groups like the International Organization for Standardization (ISO) coupled with plastic industry pioneers investing in the necessary tools to safely mold medical parts has led to an abundance of capable outsourcing options. We have gone from an era where there were no options to today’s environment rich with capable suppliers.

    Because of this, the custom molder and OEM partnership is more important than ever before. Today, the opportunity exists to create an integrated supply chain partnership that enables an OEM to protect its intellectual property, manage costs, ensure ongoing operational excellence, take care of the ability to leverage investments of people, and be a leading firm within the community.

    Additional benefits outside of manufacturing costs savings can be realized by working with an outsource partner. Time to market can be reduced by leveraging a vertically integrated prototype/production mold builder, molder, and secondary operations provider who understands the pace necessary to launch new products on time as well as process efficiency techniques like design for manufacturability.

    The right custom molder services multiple industries and processes, as that cross-pollination of experience can be leveraged to provide new insights into product design, the manufacturing process, and sustainability options. The value a custom molder can provide is worth a second look as options are analyzed.

    Evaluating the ‘Buy’ Decision
    Once the decision to outsource the molding business has been made, the next major decision is who to outsource it to. Choosing the right partner is a complex process in decision making. Further, since the medical molding landscape is crowded with many injection molders—and not all are created equal—the decision is anything but simple.

    A contract molder with internal horsepower in tooling, molding equipment, and automation can more easily overcome major challenges—like ongoing capital investments, troubleshooting, and designing the right process—and remedy situations swiftly. Whether launching a new part or seeking to improve existing product lines, consider the information needed to make the right decision.

    Simplifying Complexity with the Right Custom Molder
    Once a thorough evaluation of the barriers to molding a part in-house has been performed—ongoing resource investments, intellectual property, personnel concerns—it’s important to do the same evaluation of outsourcing molded parts. OEMs must consider the following factors when evaluating potential partners:

    Experience: Finding a partner with an extensive body of work in the field of integrating large transfer projects into their facilities or taking over yours is critical. Many custom molders will also excel at supporting new product introductions. This experience helps molders specify the right process for a company’s specific needs.

    Extensive Capabilities: Choosing a custom molder that is vertically integrated is also important for success. Finding a partner who builds tooling, automation, and also molds parts in an ISO-compliant environment—and can help manage FDA approvals—will help drive value for a project.

    Streamlined Supply Chain: Greater cost savings can be realized simply from streamlining the supply chain through a successful relationship with the right molder. The right partner will be able to act as a single source of supply, helping to design a part for manufacturability, build the right mold, select the right materials, mold the part, and provide any secondary operations required.

    Accountability: Within a streamlined supply chain, the accountability of an outsource partner will increase. If an issue with the molded parts exists, it’s fairly obvious whom to turn to for assistance to minimize risk and increase accountability.

    Not just any custom molder will bring together these four elements to support a company’s need for high-quality parts. It’s important to thoroughly vet each custom molder to ensure the right “make vs. buy” decision.

    Case in Point
    The need to make the outsourcing decision can be required for many reasons. For example, recently, a large medical device and pharmaceutical company with extensive internal molding capabilities spun off a division as its own company under a new name. During the split, the new entity did not retain any facilities with injection molding capabilities, presenting them with a significant decision—to set up shop or outsource.

    The contract was written so that the original OEM was responsible for continuing to supply molded components for a maximum period of two years. The criteria included an ISO Class 8 cleanroom environment, 16 molding machines, 24/7 operations, a fully staffed and equipped mold maintenance department with a fleet of 46 molds ranging from 10 to 25 years old, and some secondary operations.

    Since the parts were technically challenging and the molds were complex and aged, needing maintenance and repair, the company chose to outsource the molding business, selecting MGS based upon tooling horsepower and a proven track record in healthcare transfer molding. The transfer, mold repair, and validation work was 100 percent complete in six months, allowing the OEM to fulfill its commitment without the complexity associated with keeping the program in-house.

    Conclusion
    The “make vs. buy” decision is not one that should be considered lightly. There are significant expenses involved and lapses in quality cannot occur. As such, medical device OEMs should take time to perform the required due diligence to ensure they are making the correct choice for their specific business needs. 


    Bob Bordignon is vice president of global sales for MGS. He has more than 30 years of experience in custom plastics manufacturing.
    Related Searches
    • sales
    • led
    • Materials
    • plastic
    Related Knowledge Center
    • Molding
    Suggested For You
    Innovation in Medtech: Choosing an Execution Strategy Innovation in Medtech: Choosing an Execution Strategy
    Hologic Partners with MagView to Develop Unifi EQUIP Solution Hologic Partners with MagView to Develop Unifi EQUIP Solution
    Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls
    CarThera Receives FDA Approval for Phase 1/2a Trial in Glioblastoma CarThera Receives FDA Approval for Phase 1/2a Trial in Glioblastoma
    Cytek Biosciences Achieves ISO 9001:2015 Certification Cytek Biosciences Achieves ISO 9001:2015 Certification
    Beyond 510(k)/PMA: De Novo 101—Mike on Medtech Beyond 510(k)/PMA: De Novo 101—Mike on Medtech
    FDA Warning: Potential Cybersecurity Concerns with Certain Medtronic Insulin Pumps FDA Warning: Potential Cybersecurity Concerns with Certain Medtronic Insulin Pumps
    Care Points: The Current State of Point of Care Diagnostics Care Points: The Current State of Point of Care Diagnostics
    Overcoming Barriers of Adopting ISO 80369 Overcoming Barriers of Adopting ISO 80369
    J&J Helping Health Systems Address Clinician Burnout and Increase Employee Engagement J&J Helping Health Systems Address Clinician Burnout and Increase Employee Engagement
    Bal Seal Engineering Achieves USP Class VI and ISO 10993-5 Compliance for Medical Sealing Polymers Bal Seal Engineering Achieves USP Class VI and ISO 10993-5 Compliance for Medical Sealing Polymers
    Anaconda Biomed Expands Leadership Team with Two New Senior Hires Anaconda Biomed Expands Leadership Team with Two New Senior Hires
    Once or Again? Single-Use Products Are Gaining Attention Once or Again? Single-Use Products Are Gaining Attention
    IEEE Completes Standards Family Intended to Provide Safe and Secure Medical Device Interoperability IEEE Completes Standards Family Intended to Provide Safe and Secure Medical Device Interoperability
    FDA Aims to Prevent Shortages Following Sterilization Shutdowns FDA Aims to Prevent Shortages Following Sterilization Shutdowns

    Related Columns

    • Innovation in Medtech: Choosing an Execution Strategy

      Innovation in Medtech: Choosing an Execution Strategy

      ...
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 07.30.19

    • Diagnostics
      Hologic Partners with MagView to Develop Unifi EQUIP Solution

      Hologic Partners with MagView to Develop Unifi EQUIP Solution

      The automated solution will facilitate compliance with FDA guidance.
      Hologic 07.18.19

    • Digital Health | Software & IT
      Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls

      Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls

      SoomSafety is the first mobile app to close the information gap between the U.S. FDA, manufacturers, and medical device users.
      PR Newswire 07.15.19


    • Electronics | Neurological
      CarThera Receives FDA Approval for Phase 1/2a Trial in Glioblastoma

      CarThera Receives FDA Approval for Phase 1/2a Trial in Glioblastoma

      SonoCloud ultrasound device will be tested for the first time at U.S. clinical sites.
      CarThera 07.09.19

    • Cytek Biosciences Achieves ISO 9001:2015 Certification

      Cytek Biosciences Achieves ISO 9001:2015 Certification

      The certification follows an analysis of the company's QMS by TÜV Rheinland, an independent body.
      Globe Newswire 07.05.19

    Loading, Please Wait..

    Trending
    • U.K. Strengthens Medical Device Regulations
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • How Are Hypodermic Needles Made?
    • Microneedle Patch Glucose Monitor Proves Virtually Painless And More Accurate
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • First Patient Cases Using Memic's Hominis Surgical System
    • Bot Image's ProstatID AI Software Gains FDA Nod
    • Researchers Develop Deep Learning Model for Eye Disorder Screening
    • Medidata Unveils New Tech to Improve Clinical Trial Oversight
    • BD, Direct Relief, NACHC Award $1M Grant for Health Equity
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds
    3i Solutions Announces New Leadership Positions
    INS Nutra Opens Gummy Manufacturing Facility
    Coatings World

    Latest Breaking News From Coatings World

    KRATON Receives Platinum Rating from EcoVadis for Sustainability Management System
    Lanxess' Entire Value Chain to Become Climate-Neutral
    Custom Cars Featuring PPG DELTRON Refinish System Take Awards at Goodguys 24th Summit
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Researchers Develop Deep Learning Model for Eye Disorder Screening
    Medidata Unveils New Tech to Improve Clinical Trial Oversight
    BD, Direct Relief, NACHC Award $1M Grant for Health Equity
    Contract Pharma

    Latest Breaking News From Contract Pharma

    MilliporeSigma to Provide Full Viral Vector Offering with Launch of VirusExpress 293
    Charles River Receives EMA Approval to Produce Allogeneic Cell Therapy
    Romaco Group Taps Jens Torkel as VP, Sales & Customer Service
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fashion Designer Issey Miyake Dies
    Cetaphil Announces Clean Formulas & Commits to Sustainability
    Batiste Kicks Off Partnership with Fitness Brand
    Happi

    Latest Breaking News From Happi

    Hallstar To Purchase Lanxess’ Polymer Additives Production Site in Greensboro, NC
    Uber and The Body Shop Expand On-Demand Delivery Partnership Nationwide
    Australia-Based Teeth Whitening Technology Leader White Glo Enters US Market
    Ink World

    Latest Breaking News From Ink World

    Xerox Board of Directors Names Steven Bandrowczak as CEO
    ALTANA AG to Sell Its Stake in dp polar to 3D Systems
    Weekly Recap: Zeller+Gmelin, Epple Druckfarben Lead This Week’s News Stories
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Rotocontrol EMT brings hybrid printing and finishing to Labelexpo Americas
    Avery Dennison debuts next generation AD CleanFlake technology
    Eukalin acquires Adhesives Specialists
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: A New Day for Hygiene, Glatfelter Reports Q2 Results & More
    Dyper Achieves B Corp Certification
    Edgewell’s Sales Grow
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AxioMed LLC Submits Module III to FDA for Lumbar Viscoelastic Disc Replacement
    Extremity Medical Developing MIS Techniques for Foot and Ankle
    OSSIO Rolls Out OSSIOfiber Suture Anchors in U.S.
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    CdTe Accelerator Consortium Aims to Reduce Costs, Speed Deployment
    Universal Display Announces Retirement Plans of CFO Sidney D. Rosenblatt
    Fast Company Names Zebra Technologies to 2022 Best Workplaces for Innovators

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login